
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
HIV associated nephropathy pathophysiology
Introduction
Overview
Overview
HIV associated nephropathy (HIVAN) is mostly seen in patients of African decent. Some factors involving HIV associated nephropathy (HIVAN) pathology includes: HIV-1 replication in the kidney, HIV-1 gene products, increased proliferation, apoptosis and dedifferentiation of podocytes and polymorphysim of Apolipoprotein 1 (APOL1) polymorphysim gene.[1]
Pathogenesis
Pathogenesis
HIV associated nephropathy (HIVAN) is mostly seen in patients of African decent.[1]
Some factors involving HIV associated nephropathy (HIVAN) pathology includes:[1]
Pathogenesis
Viral Factors
- Proviral DNA has been reported in the renal tissue of all patients with HIV associated nephropathy (HIVAN) even in those with negative HIV-1 RNA levels in plasma.[2]
- HIV-1 can replicate in the kidney even in those patients who are on treatment.[3]Â
- HIV-1 gene products such as nef (negative effector) and vpr (viral protein r) are reported to be involved in the pathogenesis.[4]
- Increased proliferation, apoptosis and dedifferentiation of podocytes have been reported in HIVAN.[3]
Genetic Factor
High risk alleles G1 (a missense mutation) and G2 (a frameshift deletion) for Apolipoprotein 1 (APOL1) are associated with HIVAN (APOL1 gene is on chromosome 22).[5]
Gross Pathology
Gross Pathology
On gross pathology, kidneys in HIV-associated nephropathy have the following features:[6]
- Pale
- Unevenly enlarged
- Smooth cortical surface.
Microscopic Pathology
Microscopic Pathology
On microscopic pathology, kidneys in HIV-associated nephropathy have the following features:[6]
| Histopathology of HIV-associated nephropathy | ||
|---|---|---|
| Light Microscopy[6] | Electron Microscopy[6] | Immunofluorescence[6] |
|
|
|
Â
References
References
- ↑ 1.0 1.1 1.2 Waheed S, Atta MG (2014). “Predictors of HIV-associated nephropathy”. Expert Rev Anti Infect Ther. 12 (5): 555–63. doi:10.1586/14787210.2014.901170. PMID 24655211.
- ↑ Izzedine H, Acharya V, Wirden M, Cluzel P, Sene D, Lucas GM; et al. (2011). “Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies”. Nephrol Dial Transplant. 26 (2): 580–3. doi:10.1093/ndt/gfq414. PMID 20624771.
- ↑ 3.0 3.1 Medapalli RK, He JC, Klotman PE (2011). “HIV-associated nephropathy: pathogenesis”. Curr Opin Nephrol Hypertens. 20 (3): 306–11. doi:10.1097/MNH.0b013e328345359a. PMC 3153858. PMID 21358326.
- ↑ Atta MG (2010). “Diagnosis and natural history of HIV-associated nephropathy”. Adv Chronic Kidney Dis. 17 (1): 52–8. doi:10.1053/j.ackd.2009.08.005. PMID 20005489.
- ↑ Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P; et al. (2011). “APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy”. J Am Soc Nephrol. 22 (11): 2129–37. doi:10.1681/ASN.2011040388. PMC 3231787. PMID 21997394.
- ↑ 6.0 6.1 6.2 6.3 6.4 D’Agati V, Suh JI, Carbone L, Cheng JT, Appel G (1989). “Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study”. Kidney Int. 35 (6): 1358–70. PMID 2770114.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[3]Krzysztof Wierzbicki M.D. [4]
